Skip to content

CVE-2025-28243

Alteryx Server cross-site scripting (XSS)

8.0 HIGHPublic exploitEPSS 0.33%
  1. Published10 Jul 2025

Description

An issue in Alteryx Server v.2023.1.1.460 allows HTML injection via a crafted script to the pages component.

CVSS 3.1 breakdown

Attack vectorNetwork
Attack complexityHigh
Privileges requiredNone
User interactionRequired
ScopeChanged
ConfidentialityHigh
IntegrityHigh
AvailabilityNone
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:C/C:H/I:H/A:N

Affected products

Alteryx Server2023.1.1.460

Remediation

No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.

Frequently asked

Is CVE-2025-28243 being actively exploited?

CVE-2025-28243 is not in the CISA KEV catalog. A public exploit reference exists, so treat it as exploitable. Its EPSS exploit probability is 0.33%.

How severe is CVE-2025-28243?

CVE-2025-28243 has a CVSS 3.1 base score of 8.0, rated high. EPSS estimates a 0.33% probability of exploitation.

Which products are affected by CVE-2025-28243?

Affected products include Alteryx Server.

How do I fix CVE-2025-28243?

Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2025-28243 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

Get Patch this first every Monday

Five vulnerabilities that matter this week, ranked on real exploitation. Plain language, one email, no spam.

You can unsubscribe with one click from every issue. We handle your details as described in our privacy policy.

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.